Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading.Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.Merus shares jumped 38.2$95.21 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersSteakholder Foods Ltd – ADR (NASDAQ: STKH) rose 92% to $8.32 in pre-market trading. Steakholder Foods recently announced signing of agreement for the acquisition ...